Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 18/10/2019
SIETES contiene 92826 citas

 
 
 1 a 20 de 128 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE. Previous drug exposure in patients hospitalised for acute liver injury: a case-population study in the French National Healthcare Data System. Drug Saf 2019;42:abril. [Ref.ID 103083]
2. Cita con resumen
Samper E. El doble filo del ibuprofeno y otros antiinflamatorios . eldiario.es 2019:22 de abril. [Ref.ID 103079]
3.Enlace a cita original Cita con resumen
Anónimo. Towards better patient care: drugs to avoid in 2019. Prescrire Int 2019;39:abril. [Ref.ID 103075]
4.Enlace a cita original Cita con resumen
Brutcher RE, Kurihara C, Bicket MC, Moussavian-Yousef P, Reece DE, Solomon LM, Griffith SR, Jamison DE, Cohen SP. Compounded topical pain creams to treat localized chronic pain: a randomized controlled trial. Ann Intern Med 2019;170:mayo. [Ref.ID 103014]
6. Cita con resumen
Derry S, Wiffen P, Moore A. Topical nonsteroidal anti-inflammatory drugs for acute musculoskeletal pain. JAMA 2016;315:813-4. [Ref.ID 100022]
7.Enlace a cita original Cita con resumen
Anónimo. Riesgos de los AINE en pacientes que reciben tratamiento antitrombótico. Butlletí Groc 2015;28:5-10. [Ref.ID 99839]
8. Cita con resumen
Anónimo. Patientes enceintes migraineuses. Prescrire 2014;34:356-7. [Ref.ID 97565]
9.
Day RO, Graham GG. Non-steroidal anti-inflammatory drugs (NSAIDs). BMJ 2013;347:34-7. [Ref.ID 96140]
10. Cita con resumen
Castellsague J, Pisa F, Rosolen V, Drigo D, Riera-Guardia N, Giangreco M, Clagnan E, Tosolini F, Zanier L, Barbone F, Perez-Gutthann S. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy. Pharmacoepidemiol Drug Saf 2013;22:365-75. [Ref.ID 95210]
11. Cita con resumen
Moore N, Gulmez SE, Larrey D, Pageaux GP, Lignot S, Lassalle R, Jové J, Pariente A, Blin P, Bénichou J, Bégaud B. Choice of denominator in case population studies: event rates for registration for liver transplantation after exposure to NSIADs in the SALT study in France. Pharmacoepidemiol Drug Saf 2013;22:160-7. [Ref.ID 94867]
12. Cita con resumen
Ramírez E, Rossignoli T, Campos AJ, Muñoz R, Zegarra C, Tong H, Medrano N, Borobia AM, Carcas AJ, Frías J. Drug-induced life-threatening potassium disturbances detected by a pharmacovigilance program from laboratory signals . Eur J Clin Pharmacol 2013;69:97-110. [Ref.ID 94842]
13. Cita con resumen
Castellsague J, Riera-Guardia N, Calingaert B, Varas-Lorenzo C, Fourrier-Reglat A, Nicotra F, Sturkenboom M, Perez-Gutthann S, on behalf of the investigators of the Safety of Non-Steroidal Anti-Inflammatory Drugs (SOS) Project. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS) Project). Drug Saf 2012;35:1127-46. [Ref.ID 94171]
14.Enlace a cita original
Gulmez SE, Droz-Perroteau C, Lassalle R, Blin P, Bégaud B, Rossignol M, Moore N, Fourrier-Réglat A, on behalf of the CADEUS study group. Are traditional NSAIDs prescribed appropriately among French elderly with osteoarthritis? Results from the CADEUS cohort. Eur J Clin Pharmacol 2011;67:833-8. [Ref.ID 91082]
15. Cita con resumen
Velo G, Moretti U. Ecopharmacovigilance for better health. Drug Saf 2010;33:963-8. [Ref.ID 89832]
16. Cita con resumen
Massó-González EL, Patrignani P, Tacconelli S, García Rodríguez LA. Variability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleeding. Arthritis & Rheumatism 2010;62:1592-601. [Ref.ID 88551]
20. Cita con resumen
Ibáñez L, Vidal X, Laporte JR. Proton pump inhibitors and risk of upper gastrointestinal bleeding in NSAID users. Am J Gastroenterol 2008;103:2658-1659. [Ref.ID 84102]
Seleccionar todas
 
 1 a 20 de 128 siguiente >>